Evidence map›Paper›PMID 38558164›Full record

ReviewCurrent pain and headache reports2024

Diabetic Neuropathy: Pathophysiology Review.

Natalie Strand, Meredith A Anderson, Sumedha Attanti, Benjamin Gill, Christopher Wie, Azizat Dawodu, Robert Pagan-Rosado, Monica W Harbell, Jillian A Maloney

Abstract readReview
PubMed Publisher
In one paragraph

Review in Current pain and headache reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed, 1 pooled it
16.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 1 synthesis or guideline pooled it, 49 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Observational
  18. Article
  19. Article
  20. [Research on the pathogenesis and treatment of diabetic foot ulcer wounds].Zhonghua shao shang yu chuang mian xiu fu za zhi · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Natalie StrandDepartment of Anesthesiology and Perioperative Medicine, Mayo Clinic, Phoenix, AZ, USA. strand.natalie@mayo.edu.
Meredith A AndersonMayo Clinic Alix School of Medicine, Scottsdale, AZ, USA.
Sumedha AttantiMayo Clinic Alix School of Medicine, Scottsdale, AZ, USA.
Benjamin GillDepartment of Anesthesiology, University of Utah, Salt Lake City, UT, USA.
Christopher WieDepartment of Anesthesiology and Perioperative Medicine, Mayo Clinic, Phoenix, AZ, USA.
Azizat DawoduDepartment of Anesthesiology and Perioperative Medicine, Mayo Clinic, Phoenix, AZ, USA.
Robert Pagan-RosadoDepartment of Pain Medicine, Mayo Clinic, Jacksonville, FL, USA.
Monica W HarbellDepartment of Anesthesiology and Perioperative Medicine, Mayo Clinic, Phoenix, AZ, USA.
Jillian A MaloneyDepartment of Anesthesiology and Perioperative Medicine, Mayo Clinic, Phoenix, AZ, USA.
Mayo Clinic in Florida · USWinnMed · USMayo Clinic in Arizona · USUniversity of Utah · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purpose of reviewDiabetic neuropathy is a debilitating complication of diabetes mellitus that affects millions of individuals worldwide. It is characterized by nerve damage resulting from prolonged exposure to high blood glucose levels. Diabetic neuropathy may cause a range of symptoms, including pain, numbness, muscle weakness, autonomic dysfunction, and foot ulcers, potentially causing significant impairment to the quality of life for those affected. This review article aims to provide a comprehensive overview of the pathophysiology of diabetic neuropathy. The etiology of diabetic neuropathy will be discussed, including risk factors, predisposing conditions, and an overview of the complex interplay between hyperglycemia, metabolic dysregulation, and nerve damage. Additionally, we will explore the molecular mechanisms and pathways of diabetic neuropathy, including the impact of hyperglycemia on nerve function, abnormalities in glucose metabolism, the role of advanced glycation end products (AGEs), and inflammatory and immune-mediated processes. We will provide an overview of the various nerve fibers affected by diabetic neuropathy and explore the common symptoms and complications associated with diabetic neuropathy in the pain medicine field. RECENT

findingsThis review highlights advances in understanding the pathophysiology of diabetic neuropathy as well as reviews potential novel therapeutic strategies and promising areas for future research. In conclusion, this review article aims to shed light on the pathophysiology of diabetic neuropathy, its far-reaching consequences, and the evolving strategies for prevention and management. In understanding the mechanisms of diabetic neuropathy and the ongoing research in this area, healthcare professionals can better serve patients with diabetes, ultimately improving well-being and reducing complications.

Indexed as

Diabetic NeuropathiesHumansHyperglycemiaRisk FactorsAutonomic dysfunctionDiabetesNeuropathyPainful neuropathyPeripheral neuropathy

Identifiers

PMID38558164
OpenAlexW4393388169

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.